SEMA5A
SEMA5A (semaphorin 5A, also known as semF or SEMAF) is a membrane-bound member of the semaphorin family that acts as a bifunctional axonal guidance cue. Its attractive or inhibitory effects depend on the type of sulfated proteoglycan it engages. Browse Assay Genie's current range of SEMA5A research reagents below, or read on for the biology behind the target.
SEMA5A is a bifunctional axonal guidance cue whose activity is regulated by sulfated proteoglycans. Its attractive effects result from interactions with heparan sulfate proteoglycans (HSPGs), while its inhibitory effects depend on interactions with chondroitin sulfate proteoglycans (CSPGs). SEMA5A is also a ligand for the receptor PLXNB3. In glioma cells, SEMA5A stimulation of PLXNB3 causes disassembly of F-actin stress fibres, disruption of focal adhesions and cellular collapse. It also inhibits cell migration and invasion through ARHGDIA-mediated inactivation of RAC1. SEMA5A may additionally promote angiogenesis by increasing endothelial cell proliferation and migration and by inhibiting apoptosis.
The SEMA5A gene belongs to the semaphorin gene family, which encodes membrane proteins containing a semaphorin domain and several thrombospondin type-1 repeats. Members of this family are involved in axonal guidance during neural development. The SEMA5A protein is annotated as a membrane protein, and the mouse and rat orthologs are both named Sema5a.
HGNC places the gene in the semaphorin group and also lists it among microRNA protein-coding host genes. Its previous name describes its domain layout: a sema domain, seven thrombospondin repeats (type 1 and type 1-like), a transmembrane domain and a short cytoplasmic domain. The gene has been implicated as an autism susceptibility gene, which makes SEMA5A a point of interest for researchers studying neurodevelopment.
SEMA5A acts as a bifunctional guidance cue, attractive via HSPGs and inhibitory via CSPGs, making it a model for proteoglycan-regulated signalling.
The SEMA5A gene has been implicated as an autism susceptibility gene, and semaphorins are involved in axonal guidance during neural development.
SEMA5A signalling through PLXNB3 and RAC1 inactivation inhibits glioma cell migration and invasion, with loss of stress fibres and focal adhesions.
SEMA5A may promote angiogenesis by increasing endothelial cell proliferation and migration and inhibiting apoptosis.
SEMA5A is a bifunctional axonal guidance cue. It attracts axons through heparan sulfate proteoglycans and inhibits them through chondroitin sulfate proteoglycans. It is a ligand for PLXNB3 and may promote angiogenesis by supporting endothelial cell proliferation and migration.
SEMA5A is the HGNC symbol for semaphorin 5A, and the UniProt entry is named Semaphorin-5A. Aliases include semF and SEMAF. An earlier gene name described its sema domain, seven thrombospondin repeats, transmembrane domain and short cytoplasmic domain.
The SEMA5A gene has been implicated as an autism susceptibility gene. In glioma cells, its signalling through PLXNB3 inhibits migration and invasion. Mouse and rat both have a Sema5a ortholog; check the datasheet of any product for its validated reactivity.
Other semaphorin family members with products at Assay Genie, useful for comparing guidance cues in neural development and cell migration.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13591; product specifications from Assay Genie datasheets.